categorized SCLC patients into four subtypes based on expression profiles of transcriptional factors (ASCL1, NEUROD1, POU2F3, and YAP1), with each type exhibiting a distinct expression pattern and sensitivity to different therapeutic drugs (11). Here, ASCL1 is linked to small cell lung carcinoma.